Category Archives: Transhuman News

NEW YORK, Sept. 17, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

US Personalized Cancer Genome Sequencing Market

http://www.reportlinker.com/p0968380/US-Personalized-Cancer-Genome-Sequencing-Market.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Genomics

The US personalized cancer Whole-Genome Sequencing market is primarily classified into targeted genome sequencing and Whole-Genome Sequencing. Our report entitled "US Personalized Cancer Genome Sequencing Market" takes into account the Whole-Genome Sequencing services, i.e. one of the most attractive sectors due to its inherent capability of high revenue generation and efficiency in terms of personalized treatment. The US, which is the frontrunner in the provision of such high-end service, is on the focus by market players because of favorable demographics and rising awareness among the industry participants.

In order to properly analyze the virtues and significance of the US personalized cancer Whole-Genome Sequencing market, our report has effectively studied the current and future status of cancer in the whole country as well as states. In view of the fact that cancer affects some age groups in a significant manner, we have also investigated the age wise statistics of the disease. To get proper insight into the market, an in-depth analysis into the high-income group population is provided so that players can have a clear picture about their potential customer base and market to be tapped.

An in-depth study of the regulatory environment governing the US personalized cancer Whole-Genome Sequencing market has also been provided. It has been found that regulations related to personalized cancer sequencing are primarily governed with the accreditation of the laboratories performing the sequencing services and analysis and also the usage of FDA approved tests for conducting these tests. Further we have also discussed the various constraints faced by the industry players with suitable suggestions for overcoming them.

The report analyzes the competitive landscape in the market through properly analyzing the business, services and activities of the companies. It also provides the competitive benchmarking taking into account the strengths and weaknesses of each player. Overall, the report is a complete source of knowledge and statistics for the clients who want to get an in-depth understanding of the market.

1. Analyst View

2. Research Methodology

3. Cancer Statistics by Demographics

See more here:
US Personalized Cancer Genome Sequencing Market

Non-coding regions of the human genome play a larger role in cell function than previously thought, scientists from Yale and other schools have shown.

Scientists from Yale and an international research consortium recently published the discovery of information identifying functional regions of the human genome.

Whereas the human genome, sequenced under the worldwide Human Genome Project in 2003, defines the overall structure of human DNA, the new project, titled Encode (ENCyclopedia Of DNA Elements), investigated how many of the elements of DNA work to control activity within the body. The results of Encode, published in over two dozen scientific journals, annotated the human genome by identifying regions previously considered junk as essential for determining cell function. Knowledge gained by the project will help scientists better understand the role of genes in human development and disease, said Sherman Weissman, professor of genetics at the Yale School of Medicine and a member of the project.

The Yale division of Encode was led by Michael Snyder, former chairman of the Yale Department of Molecular, Cellular and Developmental Biology, and launched worldwide in 2003 with a grant from the National Human Genome Research Institute.

John Rinn GRD 04, an assistant professor of stem cell and regenerative biology at Harvard University who was not part of Encode, said that the Human Genome Project left scientists with enormous quantities of unanalyzed information. The purpose of Encode, he said, was to decode those uncharted territor[ies].

Like Magellan navigating the ocean, [Encode] set out to make maps of the genome, Rinn said.

Every cell contains the entire genome, but only reads certain parts for example, a liver cell reads only the section describing the liver, and disposes of the remainder of the genome, Rinn said.

Encode mapped the presence of certain regions containing noncoding RNA, which organizes and determines the activities of various cells by deciding which section of the genome is read for each cell. Scientists were surprised to discover that noncoding RNA exists in equal quantities as messenger RNA (mRNA) that plays a role in protein building.

Weissman said that the results will facilitate other genetic research.

If you want to study an unknown gene, now you can look at [Encode] and see what kind of proteins bind to the DNA near it, or the control sites of nearby DNA, Weissman said. It saves individual laboratories from doing studies on single genes.

See the original post:
Yale maps “uncharted” genome regions